A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline

Renuka Shanmugalingam; Angela Makris

doi:10.5694/mja2.52576

A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline

Renuka Shanmugalingam
, Angela Makris

School of Medicine

Liverpool Hospital

Research output: Contribution to journal › Article

2 Citations (Scopus)

Abstract

We thank Latino and Ayonrinde1 for raising an important discussion on the association between metabolic dysfunction- associated steatotic liver disease (MASLD)/metabolic dysfunction- associated fatty liver disease (MAFLD) and hypertensive disorders of pregnancy (HDP).

Original language	English
Pages (from-to)	158-159
Number of pages	2
Journal	Medical Journal of Australia
Volume	222
Issue number	3
DOIs	https://doi.org/10.5694/mja2.52576
Publication status	Published - 17 Feb 2025

Keywords

Hypertension; Pregnancy

Access to Document

10.5694/mja2.52576

Cite this

@article{13ed168426d94fe1a72b47fccd4167a8,

title = "A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline",

abstract = "We thank Latino and Ayonrinde1 for raising an important discussion on the association between metabolic dysfunction- associated steatotic liver disease (MASLD)/metabolic dysfunction- associated fatty liver disease (MAFLD) and hypertensive disorders of pregnancy (HDP).",

keywords = "Hypertension; Pregnancy",

author = "Renuka Shanmugalingam and Angela Makris",

year = "2025",

month = feb,

day = "17",

doi = "10.5694/mja2.52576",

language = "English",

volume = "222",

pages = "158--159",

journal = "Medical Journal of Australia",

issn = "0025-729X",

publisher = "Australasian Medical Publishing Company",

number = "3",

}

TY - JOUR

T1 - A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline

AU - Shanmugalingam, Renuka

AU - Makris, Angela

PY - 2025/2/17

Y1 - 2025/2/17

N2 - We thank Latino and Ayonrinde1 for raising an important discussion on the association between metabolic dysfunction- associated steatotic liver disease (MASLD)/metabolic dysfunction- associated fatty liver disease (MAFLD) and hypertensive disorders of pregnancy (HDP).

AB - We thank Latino and Ayonrinde1 for raising an important discussion on the association between metabolic dysfunction- associated steatotic liver disease (MASLD)/metabolic dysfunction- associated fatty liver disease (MAFLD) and hypertensive disorders of pregnancy (HDP).

KW - Hypertension; Pregnancy

UR - https://www.scopus.com/pages/publications/85213340396

UR - https://go.openathens.net/redirector/westernsydney.edu.au?url=https://doi.org/10.5694/mja2.52576

U2 - 10.5694/mja2.52576

DO - 10.5694/mja2.52576

M3 - Article

AN - SCOPUS:85213340396

SN - 0025-729X

VL - 222

SP - 158

EP - 159

JO - Medical Journal of Australia

JF - Medical Journal of Australia

IS - 3

ER -

A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this